Coloplast A/S (OTCPK:CLPBF) Q3 2022 Earnings Conference Call August 17, 2022 9:00 a.m.
The following slide deck was published by Coloplast A/S in conjunction with their 2022 Q3 earnings call.
The following slide deck was published by Coloplast A/S in conjunction with their 2022 Q2 earnings call.
The US equity market rally extended modestly yesterday, but turned tail upon the cash S&P 500 Index touching the key 200-day moving average at 4,325. Market today will eye the latest US Retail Sales report from July, which saw peak gasoline prices in the US mid-month, while the FOMC Minutes may prove a bit stale, given they were created before three weeks of the market rallying sharply and financial conditions easing aggressively, likely not the Fed’s intention. What is our trading focus? Nasdaq 100 (USNAS100.I) and S&P 500 (US500.I) S&P 500 futures broke above the 200-day moving average yesterday and then got rejected. Momentum in US equities got a bit more fuel from two good earnings releases from Home Depot and Walmart rising 4% and 5% respectively. S&P 500 futures are pushing higher again this morning and will likely attempt once more to break above the 200-day moving average. Long-term US interest rates are still well-behaved trading around the 2.8% level and the VIX Index has stabilised just below the 20 level.
No summary available.
A federal judge in Minnesota granted summary judgment to Coloplast in a lawsuit over the company’s transvaginal mesh. Angela Dawn Cantrell received the Restorelle L mesh implant as part of a surgery to correct vaginal prolapse in January 2018. Cantrell continued to experience pain and pelvic floor dysfunction after the surgery and underwent additional surgeries. […]